Thorac Cardiovasc Surg 2022; 70(S 01): S1-S61
DOI: 10.1055/s-0042-1742803
Oral and Short Presentations
Sunday, February 20
Univentricular Hearts

Management of Failing Bidirectional Cavopulmonary Shunt: Impact of Additional Systemic to Pulmonary Artery Shunt with Classic Glenn Physiology

C. Euringer
1   Department of Congenital and Pediatric Heart Surgery, Deutsches Herzzentrum München, München, Deutschland
,
T. Kido
2   Department of Congenital and Pediatric Heart Surgery, Deutsches Herzzentrum München, Munich, Deutschland
,
B. Ruf
3   Department of Pediatric Cardiology and Congenital Heart Disease, Deutsches Herzzentrum München, Munich, Deutschland
,
M. Burri
4   Department of Cardiovascular Surgery, German Heart Center Munich, Munich, Deutschland
,
P. P. Heinisch
2   Department of Congenital and Pediatric Heart Surgery, Deutsches Herzzentrum München, Munich, Deutschland
,
J. Vodiskar
2   Department of Congenital and Pediatric Heart Surgery, Deutsches Herzzentrum München, Munich, Deutschland
,
M. Strbad
2   Department of Congenital and Pediatric Heart Surgery, Deutsches Herzzentrum München, Munich, Deutschland
,
J. Cleuziou
2   Department of Congenital and Pediatric Heart Surgery, Deutsches Herzzentrum München, Munich, Deutschland
,
D. Dilber
5   Department of Pediatrics, University Hospital Centre Zagreb, Zagreb, Croatia
,
A. Hager
3   Department of Pediatric Cardiology and Congenital Heart Disease, Deutsches Herzzentrum München, Munich, Deutschland
,
P. Ewert
3   Department of Pediatric Cardiology and Congenital Heart Disease, Deutsches Herzzentrum München, Munich, Deutschland
,
J. Hörer
2   Department of Congenital and Pediatric Heart Surgery, Deutsches Herzzentrum München, Munich, Deutschland
,
M. Ono
2   Department of Congenital and Pediatric Heart Surgery, Deutsches Herzzentrum München, Munich, Deutschland
› Author Affiliations
 

    Background: Hypoxemia in the early postoperative period after bidirectional cavopulmonary shunt (BCPS) is a critical complication. We aimed to evaluate patients who underwent additional systemic to pulmonary shunt and septation of central pulmonary artery (partial takedown) after BCPS.

    Method: The medical records of the patients who underwent BCPS between 2007 and 2020 were reviewed. Patients who underwent partial takedown were extracted and evaluated.

    Results: Of 441 BCPS patients, 26 patients (6%) required partial takedown. Most frequent diagnosis was hypoplastic left heart syndrome (n = 13, 50%) and most frequent stage I palliation was Norwood procedure (n = 17, 65%). Additional complicating factors included pulmonary artery (PA) hypoplasia (n = 12), pulmonary venous obstruction (PVO, n = 3), or high PA pressure > 15 mm Hg (n = 4). Twelve patients underwent partial takedown on the same day of BCPS and survived. The remaining 14 patients (54%) received partial takedown between postoperative days 1 and 64. Reasons for partial takedown were postoperative high pulmonary vascular resistance (n = 4), early BCPS (< 90 days) with PA hypoplasia (n = 3), mediastinitis/pneumonia (n = 3), PVO (n = 2), ventricular dysfunction (n = 1), and recurrent pneumothorax (n = 1). Four patients died in the hospital. All 22 hospital survivors were followed up for a median of 22 months. Six patients died after discharge, 10 achieved Fontan completion, and 5 were alive and waiting for Fontan. PVO (p = 0.041) and genetic/extracardiac anomalies (p = 0.085) were identified as risks for mortality after partial takedown.

    Conclusion: Partial takedown after BCPS with unilateral Glenn and contralateral systemic to pulmonary shunt is a successful alternative to complete takedown for patients with inadequate pulmonary perfusion. Fontan completion can be achieved in more than half of the patients ([Table 1]).

    Table 1

    Preoperative variables influencing survival after partial takedown with Cox regression model

    Variables

    Univariate model

    Multivariate model

    p-Value

    HR

    95% CI

    p-Value

    HR

    95% CI

    UAVSD

    0.031

    4.662

    1.2–18.8

    Genetic/extracardiac anomaly

    0.053

    3.369

    1.0–11.5

    0.085

    4.321

    0.8–22.8

    PAP >15 mm Hg

    0.079

    4.436

    0.8–23.4

    PVO

    0.021

    10.499

    1.4–72.7

    0.041

    8.936

    1.1–73.1

    PTD on separate days

    0.057

    3.675

    1.0–14.0


    #

    No conflict of interest has been declared by the author(s).

    Publication History

    Article published online:
    03 February 2022

    © 2022. Thieme. All rights reserved.

    Georg Thieme Verlag KG
    Rüdigerstraße 14, 70469 Stuttgart, Germany